Drug Trial Radar · NCT00661635
A Randomized, Double-Blind Study of the Efficacy and Safety of Valdecoxib Compared to Placebo for Treatment of Post- Cholecystectomy Surgery Pain
Last checked: Nov 20, 2026Latest source record: Apr 23, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
490
Actual
Start
Nov 2002
Primary completion
Not stated
Study completion Jul 2003
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Apr 18, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the analgesic efficacy, general safety, and effects on health outcome measures and opioid-related symptoms of 2 valdecoxib dosing regimens compared with placebo in patients with moderate or severe pain following laparoscopic cholecystectomy surgery.
Conditions
- Laparoscopic Cholecystectomy
- Pain
Interventions
placeboDrug
valdecoxib 40 mg by mouth within 8 hours after the end of surgery, followed by a second dose of valdecoxib 20 mg within 1 to 12 hours (or by midnight on the Day 1, whichever was earlier); then, placebo twice daily (BID) on Days 2 to 5
valdecoxibDrug
valdecoxib 40 mg by mouth within 8 hours after the end of surgery, followed by a second dose of valdecoxib 20 mg within 1 to 12 hours (or by midnight on the Day 1, whichever was earlier); then, valdecoxib 20 mg once daily (QD)on Days 2 to 5.
valdecoxibDrug
valdecoxib 40 mg by mouth within 8 hours after the end of surgery, followed by a second dose of valdecoxib 20 mg within 1 to 12 hours (or by midnight on the Day 1, whichever was earlier); then, valdecoxib 20 mg twice daily (BID) on Days 2 to 5.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patient's Global Evaluation of Study MedicationTime frame: Day 2 and Day 3
- Summed Pain Intensity (categorical) through 24 hours (SPI 24)Time frame: Day 2 and Day 3
Locations
65 sites in 1 country. Site status is shown where the registry gives one.
Pfizer Investigational Site
Birmingham, Alabama
Pfizer Investigational Site
Daphne, Alabama
Pfizer Investigational Site
Fairhope, Alabama
Pfizer Investigational Site
Mobile, Alabama
Pfizer Investigational Site
Mobile, Alabama
Pfizer Investigational Site
Sheffield, Alabama
Pfizer Investigational Site
Glendale, Arizona
Pfizer Investigational Site
Glendale, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Tucson, Arizona
Pfizer Investigational Site
Tucson, Arizona
Pfizer Investigational Site
Tucson, Arizona
Pfizer Investigational Site
Anaheim, California
Pfizer Investigational Site
Bakersfield, California
Pfizer Investigational Site
Bakersfield, California
Pfizer Investigational Site
Los Angeles, California
Pfizer Investigational Site
Los Angeles, California
Pfizer Investigational Site
Pasadena, California
Pfizer Investigational Site
Sacramento, California
Pfizer Investigational Site
San Jose, California
Pfizer Investigational Site
Woodland, California
Pfizer Investigational Site
Miami, Florida
Pfizer Investigational Site
Miami, Florida
Pfizer Investigational Site
Pensacola, Florida
Pfizer Investigational Site
Blue Ridge, Georgia
Pfizer Investigational Site
Marietta, Georgia
Pfizer Investigational Site
Chicago, Illinois
Pfizer Investigational Site
Maywood, Illinois
Pfizer Investigational Site
Iowa City, Iowa
Pfizer Investigational Site
Shreveport, Louisiana
Pfizer Investigational Site
Baltimore, Maryland
Pfizer Investigational Site
Germantown, Maryland
Pfizer Investigational Site
Rockville, Maryland
Pfizer Investigational Site
Silver Spring, Maryland
Pfizer Investigational Site
Jackson, Mississippi
Pfizer Investigational Site
Durham, North Carolina
Pfizer Investigational Site
Winston-Salem, North Carolina
Showing 40 of 65 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.